摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethyl 4-phenyl-2-propyl-1,3-oxazole-5-carboxylate | 1240267-10-0

中文名称
——
中文别名
——
英文名称
Ethyl 4-phenyl-2-propyl-1,3-oxazole-5-carboxylate
英文别名
——
Ethyl 4-phenyl-2-propyl-1,3-oxazole-5-carboxylate化学式
CAS
1240267-10-0
化学式
C15H17NO3
mdl
——
分子量
259.305
InChiKey
FLOIUSKLLLDSEC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    19
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    52.3
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    Ethyl 4-phenyl-2-propyl-1,3-oxazole-5-carboxylate二异丁基氢化铝 作用下, 以 二氯甲烷 为溶剂, 以95%的产率得到(4-Phenyl-2-propyl-1,3-oxazol-5-yl)methanol
    参考文献:
    名称:
    Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers
    摘要:
    T-type calcium channel is one of therapeutic targets for the treatment of cardiovascular diseases and neuropathic pain. In this study, as a part of our ongoing efforts to develop potent T-type calcium channel blockers, we designed oxazole derivatives substituted with arylpiperazinylalkylamines. The oxazoles were synthesized in a convenient convergent synthetic method, and biologically evaluated against alpha(1G) (Ca(V)3.1) T-type calcium channel. Among total 41 oxazole compounds synthesized, the most active one was the compound 10-35 with an IC(50) value of 0.65 mu M, which is comparable with that of mibefradil. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.05.030
  • 作为产物:
    描述:
    丁酰胺ethyl 2-(((2,4-dinitrophenyl)sulfonyl)oxy)-3-oxo-3-phenylpropanoate乙腈 为溶剂, 反应 0.01h, 以48%的产率得到Ethyl 4-phenyl-2-propyl-1,3-oxazole-5-carboxylate
    参考文献:
    名称:
    Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers
    摘要:
    T-type calcium channel is one of therapeutic targets for the treatment of cardiovascular diseases and neuropathic pain. In this study, as a part of our ongoing efforts to develop potent T-type calcium channel blockers, we designed oxazole derivatives substituted with arylpiperazinylalkylamines. The oxazoles were synthesized in a convenient convergent synthetic method, and biologically evaluated against alpha(1G) (Ca(V)3.1) T-type calcium channel. Among total 41 oxazole compounds synthesized, the most active one was the compound 10-35 with an IC(50) value of 0.65 mu M, which is comparable with that of mibefradil. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.05.030
点击查看最新优质反应信息